U.S. Hotel and Resort REITs Stock News

In the past week, Butterfly Network, Inc. reported record second-quarter 2026 results, with revenue rising to US$32.61 million from US$23.38 million a year earlier and net loss narrowing to US$12.91 million, while also issuing third-quarter revenue guidance of US$26 million to US$30 million. The company raised its full-year 2026 revenue outlook to US$119 million–US$123 million, underpinned by very large Embedded segment growth, new partnerships, and improved gross margins. Next, we’ll...

PTC Therapeutics stock just dropped almost 10% in a single session, yet the quarter it reported is the sort of print that usually forces investors to rerun their models rather than hit the sell button. The company delivered Q2 2026 revenue of about US$360.5m and swung to roughly US$1.01 in basic earnings per share, a sharp turn from the small loss in Q1. That combination of strong top line and a move back into the black, set against a sliding share price, is the expectation gap that matters...

Xenia Hotels & Resorts stock ticked up about 2.5% to US$20.58 into the close, which suggests traders liked the headline as well as the story around it. The key reason is straightforward: management raised full year adjusted EBITDA for real estate guidance and pointed to stronger revenue per available room, the core health check for a hotel real estate investment trust. In the short term, that helps explain today’s move. Over the longer term, it prompts investors to weigh a richer earnings...

Check Point Software slipped less than 1% on the day, even though the earnings story is far more about quiet strength than drama. The stock came into this report with modest declines over the past week and month, yet Q2 showed solid cyber security fundamentals, including revenue of US$673.6m and basic earnings per share of US$1.88. Combined with a trailing P/E of 12.4x and a net margin of 37.9%, the reaction looks more like a shrug than a verdict. The real question now is how investors weigh...

In late July 2026, the U.S. government awarded Lockheed Martin a seven-year undefinitized contract action modification worth up to US$53.86 billion for PAC-3 Missile Segment Enhancement interceptors, expanding a multiyear agreement now totaling about US$58.62 billion and supporting capacity expansion and job growth at its Camden, Arkansas facility. This major long-term PAC-3 MSE award, alongside Lockheed Martin’s recent revenue and earnings growth and upgraded 2026 guidance, highlights how...

PBF Energy stock slipped 1.1% to US$72.28 even as the company reported one of the heaviest hitting refinery earnings results on the market this season. The headline is simple. Q2 delivered refinery level profits that put Basic EPS at US$7.66 and net income at US$906.4m, powered by strong crack spreads and tight product supply. The mood in the share price looks cautious. The financials read more like a sentiment stress test. Investors now have to decide whether this earnings power is a new...

Cohu stock snapped a rough month with a 3.3% jump to US$47.99, even though the longer 30 day stretch still leaves shares down sharply. The spark was not a return to big profits. The spark was how sharply the quarterly loss narrowed relative to recent history while revenue reached US$149.0m. The sentiment turning point is about one thing. The earnings squeeze that has weighed on Cohu for several quarters eased meaningfully, and the market quickly treated that margin relief as the headline, not...

Alnylam Pharmaceuticals just put up blockbuster TTR drug revenue while the stock barely moved. Shares closed at US$205.52, essentially flat on the day, even as second quarter net product sales reached about US$1.2b and global transthyretin amyloidosis revenue crossed US$1b in a single quarter for the first time. That muted one day reaction sits awkwardly against a company that is now solidly profitable on a trailing twelve month basis and posting several hundred million dollars of non GAAP...

Camping World Holdings slipped 1.8% to close at US$6.19, a muted reaction given the headline from Q2. The company swung back to profit with basic earnings per share of US$0.42 and net income of US$26.86 million, even as revenue held around US$1.9b in a still soft recreational vehicle retail market. The real story for long term investors is not this quarter’s rebound but whether that profit can outlast a tougher cycle. Management has cut adjusted EBITDA guidance and highlighted margin pressure...

Grand Canyon Education stock slipped about 3% to US$145.34 the day after its Q2 release, even though the core story was an earnings beat and firmer profitability. Adjusted diluted earnings per share landed at US$1.81, comfortably ahead of Wall Street expectations, and operating margin sat at 22% on US$264.0m of service revenue. For a company often framed as a slow, ex growth education services business, this quarter put the focus back on operational execution rather than the share price drift...

In late July 2026, Sunrun prepared to report quarterly results expected to show an earnings decline compared with a year earlier, even as revenue was projected to increase, with third‑party indicators pointing to a low likelihood of an upside surprise. This combination of weaker anticipated profitability alongside higher sales highlights the tension between Sunrun’s growth ambitions and the challenges of turning that growth into consistent earnings. Next, we’ll examine how the expected...

The market gave LSB Industries a small shrug. The stock slipped about 1.5% to US$10.88, even though the headline from this quarter is not about collapse but about a sharp profit squeeze. After a profitable Q1, LSB reported a basic loss per share of US$0.09 and a swing to a net loss of US$6.2m on roughly flat revenue near US$168m. That disconnect is the story. Price action hints at mild disappointment. The earnings print points to a much harsher reset in margins that investors now need to...

Madrigal Pharmaceuticals stock just dropped 5.2% on the day, yet the earnings story centers on a very different kind of pressure. The market is reacting to a headline loss, while the real strain sits in a widening profit gap created by heavy investment behind Rezdiffra and an expanding commercial footprint. Q2 net sales reached US$364.3m and trailing 12 month revenue hit about US$1.3b, strong figures for a mid stage biotech. Still, Madrigal Pharmaceuticals reported a Q2 net loss of US$57.9m...

Labcorp Holdings came into this earnings print with the stock quietly grinding higher over the past quarter, then gave back about 2% to close near US$309 as investors reacted to the headlines. The move masks what actually mattered. Q2 delivered higher revenue of US$3.7b and Basic EPS of US$3.66, alongside firmer profitability at the enterprise level. The real story is margin quality. Trailing net margin now sits at 7% versus 5.7% a year earlier, and management raised full year revenue and...

The market barely blinked at Mechanics Bancorp’s latest earnings, with the stock up about 1% today, yet the report carries more emotion than that quiet move suggests. You are looking at a bank that just printed Q2 net income of US$57.7m with basic earnings per share of about US$0.25 and a net interest margin of 3.62%. The real heartbeat is cost discipline. The cost to income ratio sits at 58.4%, and management is already talking about a leaner expense base ahead. The price reaction looks calm...

Agios Pharmaceuticals investors woke up to a painful reset. The stock dropped 8.3% to close at US$30.02, extending a weak one month stretch. At the same time, the latest quarter put the spotlight on a different fault line. Q2 2026 delivered US$44.7m in revenue but also a net loss of US$100.7m, keeping the focus squarely on the size and persistence of the cash burn. The market is reacting to the near term hit, but the real question now sits on a longer horizon. Can a rare disease portfolio...

Live Nation Entertainment stock took a hit today, dropping about 5% after investors digested the latest quarter. The move comes even as Q2 delivered roughly US$7.7b in revenue and swung back to earnings per share of about US$1.26, a sharp contrast to the loss in Q1. The short-term reaction is focused on worry over timing and cash demands. The longer story centers on whether a still unprofitable trailing twelve month profile can shift, with management currently emphasizing record concert...

Blackstone Mortgage Trust came into this earnings print already on the back foot, with the stock down sharply over the past quarter and sliding another 2.9% today to about US$14.50. The big headline is not a small earnings miss. It is a sizable quarterly hit to book value and a GAAP loss tied to heavier credit reserves and impairments, even as the portfolio is being reshaped away from older office loans. For income focused investors, the immediate question is simple: Can a US$0.47 dividend...

Neogen stock jumped 4.4% to US$12.04 into the close, even though the headline earnings story is still about loss making operations. The company delivered fourth quarter revenue of US$225.3m and adjusted EBITDA margins a little above 20%, which puts the focus squarely on profitability rather than top line scale. Short term traders are reacting to signs of margin repair and better cash generation. Longer term holders will be weighing those improving Food Safety margins against a still weak...

Willis Towers Watson stock barely flinched after earnings, slipping just 0.04% to about US$335. You might think that kind of flat reaction means a routine quarter. The headline is sharper than that. Organic revenue rose 5% and adjusted operating margin reached 19.5%, helped by an adjusted earnings per share figure of US$3.35. In the short term, the market looks relaxed. Over a longer horizon, the story is more serious. Management has put margins at the center of the playbook with its multi...

APi Group walked into this earnings day with a stock that had slipped over the past three months, yet the market’s first take was a muted 1.2% gain to about $39.68. That modest move understates the headline. The story this quarter is margin power. Adjusted earnings per share climbed to $0.44 and adjusted earnings before interest, tax, depreciation and amortization margin reached 13.8%, alongside net revenue of about $2.25b. For a fire and life safety and specialty services company that...

ADT went into this earnings print carrying a value label, with the stock trading at about $7.64 and a trailing P/E well below many consumer services peers. The market reaction was calm, with the share price up just 1.7% on the day. The headline from the quarter was strong cash generation. Adjusted free cash flow reached $406 million in Q2 and $820 million year to date, while adjusted income from continuing operations held at $180 million and $0.23 per share. For a security business built on...

Employers Holdings stock slipped 2% to US$50.55 into the close, even as the latest quarter delivered a sharp earnings rebound that sits awkwardly with the market’s cool response. For a workers compensation insurer, the headline is clear. Basic earnings per share came in at about US$1.60 and the combined ratio sat near 106%, while book value per share, including deferred gains, reached US$52.58. The price is now a touch below that book value marker, so today’s modest pullback looks more like a...

Healthcare Realty Trust came into this earnings print as a recovery income story, with the stock up over the past quarter yet still carrying a history of losses. The market did not cheer the latest numbers. Shares slipped about 2.4% to US$21.01 after the Q2 report. The headline for investors is not earnings per share. It is the engine of a real estate investment trust: funds from operations. Management raised full year normalized funds from operations guidance to a midpoint of US$1.64 per...